全文获取类型
收费全文 | 208833篇 |
免费 | 2830篇 |
国内免费 | 108篇 |
专业分类
耳鼻咽喉 | 1555篇 |
儿科学 | 8492篇 |
妇产科学 | 3660篇 |
基础医学 | 20849篇 |
口腔科学 | 2302篇 |
临床医学 | 14725篇 |
内科学 | 37526篇 |
皮肤病学 | 1488篇 |
神经病学 | 18190篇 |
特种医学 | 9651篇 |
外科学 | 33371篇 |
综合类 | 3623篇 |
一般理论 | 15篇 |
预防医学 | 20049篇 |
眼科学 | 4231篇 |
药学 | 12770篇 |
中国医学 | 898篇 |
肿瘤学 | 18376篇 |
出版年
2023年 | 238篇 |
2022年 | 672篇 |
2021年 | 1165篇 |
2020年 | 644篇 |
2019年 | 870篇 |
2018年 | 22747篇 |
2017年 | 17891篇 |
2016年 | 20273篇 |
2015年 | 1855篇 |
2014年 | 2107篇 |
2013年 | 2456篇 |
2012年 | 9218篇 |
2011年 | 23207篇 |
2010年 | 19993篇 |
2009年 | 12587篇 |
2008年 | 21074篇 |
2007年 | 23225篇 |
2006年 | 2210篇 |
2005年 | 3459篇 |
2004年 | 4657篇 |
2003年 | 5424篇 |
2002年 | 3409篇 |
2001年 | 1073篇 |
2000年 | 1261篇 |
1999年 | 878篇 |
1998年 | 499篇 |
1997年 | 406篇 |
1996年 | 306篇 |
1995年 | 312篇 |
1994年 | 269篇 |
1993年 | 205篇 |
1992年 | 532篇 |
1991年 | 485篇 |
1990年 | 548篇 |
1989年 | 468篇 |
1988年 | 407篇 |
1987年 | 393篇 |
1986年 | 370篇 |
1985年 | 351篇 |
1984年 | 280篇 |
1983年 | 239篇 |
1982年 | 163篇 |
1979年 | 232篇 |
1978年 | 156篇 |
1977年 | 183篇 |
1975年 | 176篇 |
1974年 | 201篇 |
1973年 | 183篇 |
1972年 | 173篇 |
1971年 | 161篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
A trial of thyroxine in acute renal failure 总被引:7,自引:0,他引:7
Acker CG Singh AR Flick RP Bernardini J Greenberg A Johnson JP 《Kidney international》2000,57(1):293-298
A trial of thyroxine in acute renal failure. BACKGROUND: Acute renal failure (ARF) remains a serious medical problem with a high mortality rate. Efforts to shorten the course of ARF might reduce this mortality. Since thyroxine has been shown in experimental models to shorten the course of ARF, we designed a trial to determine if a defined course of thyroxine would alter the course or change the mortality of clinical ARF. METHODS: A prospective, randomized, placebo-controlled, double-blind trial of thyroxine was carried out in patients with ARF. End points were the percentage requiring dialysis, the percentage recovering renal function, time to recovery, and mortality. RESULTS: Fifty-nine patients were randomized to receive either thyroxine or placebo. The groups were well matched in terms of basal and entry creatinines, age, sex, APACHE II scores at entry, and percentage oliguric. Baseline thyroid functions, including T3, T4, rT3, and thyroid stimulating hormone (TSH) levels, were equal between the two groups and typical of patients with euthyroid sick syndrome. Thyroxine resulted in a progressive and sustained suppression of TSH levels in the treated group, but had no effect on any measure of ARF severity. Mortality was higher in the thyroxine group than the control group (43 vs. 13%) and correlated with suppression of TSH. CONCLUSIONS: In contrast to the beneficial effects seen in experimental ARF, thyroxine has no effect on the course of clinical ARF and could have a negative effect on outcome through prolonged suppression of TSH. Critically ill euthyroid sick patients should not be replaced with thyroid hormone. 相似文献
992.
Singh M Vijayaraghavan R Pant SC Sugendran K Kumar P Singh R Purnanand 《Biomedical and environmental sciences : BES》2000,13(2):90-96
One of the most potent rodenticides is 2-fluoroacetamide)2-FA).Toxicity of this chemical is well documented.However,its inhalation toxicity data is not available in the literature.Hence,acute inhalation toxicity study was carried out by exposing male and female rats to aerosols of 2-FA at different concentrations for 4h in a dynamically operated whole body inhalation exposure chamber.During and after the inhalation exposure the rats were less active,and showed mild tremors and convulsions.At higher concentrations the rats died after2-3 days.The estimated 4-h LC50 for male and female rats was 136.6 and 144.5mg.m^-3 respectively.Exposure to 0.7 LC50 for 4h duration showed an increase in the liver weight of male and female rats 7 days after exposure.Various haematological and biochemical variables determined were within the normal limits.Howerver,histological findings showed injured lung as indicated by desquamtion and necrosis of the epithelium of the respiratory tract.Marked hypertorphy of hepatocytes displaying strong acidophilic granulated cytoplasm was observed.Focal dilatation of renal proximal tubules in kidney with cytoplasmic vacuolation,and irregularly placed pyknotic nuclei were seen.The present study shows that 2-FA is a highly toxic chemical through the inhalation route based on the LC50 value.Consequently necessary precautions should be taken during its handling. 相似文献
993.
994.
S. C. Gupta Arun Goel P. A. Singh 《Indian journal of otolaryngology and head and neck surgery》1998,50(3):298-301
Laryngocele is an extremely rare condition. A case of external laryngocele is being reported along with a brief review on
its pathogenesis, clinical presentation and management. 相似文献
995.
Effect of calcium carbonate on the absorption of levothyroxine 总被引:3,自引:0,他引:3
Context The effect of calcium carbonate on the absorption of levothyroxine has not been studied systematically. Such a potential drug interaction merits investigation because concurrent treatment with both drugs is common, particularly in postmenopausal women. Objective To investigate the potential interference of calcium carbonate in the absorption of levothyroxine. Design Prospective cohort study conducted from November 1998 to June 1999, supplemented with an in vitro study of thyroxine (T4) binding to calcium carbonate. Setting Veterans Affairs Medical Center in West Los Angeles, Calif. Patients Twenty patients (age range, 27-78 years; n=11 men) with hypothyroidism who were taking a stable long-term regimen of levothyroxine were included in the study. All patients had serum free T4 and thyrotropin values in the normal range before beginning the study. Intervention Subjects were instructed to take 1200 mg/d of elemental calcium as calcium carbonate, ingested with their levothyroxine, for 3 months. Main Outcome Measures Levels of free T4, total T4, total triiodothyronine (T3), and thyrotropin, measured in all subjects at baseline (while taking levothyroxine alone), at 2 and 3 months (while taking calcium carbonate and levothyroxine), and 2 months after calcium carbonate discontinuation (while continuing to take levothyroxine). Results Mean free T4 and total T4 levels were significantly reduced during the calcium period and increased after calcium discontinuation. Mean free T4 levels were 17 pmol/L (1.3 ng/dL) at baseline, 15 pmol/L (1.2 ng/dL) during the calcium period, and 18 pmol/L (1.4 ng/dL) after calcium discontinuation (overall P<.001); mean total T4 levels were 118 nmol/L (9.2 µg/dL) at baseline, 111 nmol/L (8.6 µg/dL) during the calcium period, and 120 nmol/L (9.3 µg/dL) after calcium discontinuation (overall P=.03). Mean thyrotropin levels increased significantly, from 1.6 mIU/L at baseline to 2.7 mIU/L during the calcium period, and decreased to 1.4 mIU/L after calcium discontinuation (P=.008). Twenty percent of patients had serum thyrotropin levels higher than the normal range during the calcium period; the highest observed level was 7.8 mIU/L. Mean T3 levels did not change during the calcium period. The in vitro study of T4 binding to calcium showed that adsorption of T4 to calcium carbonate occurs at acidic pH levels. Conclusions This study of 20 patients receiving long-term levothyroxine replacement therapy indicates that calcium carbonate reduces T4 absorption and increases serum thyrotropin levels. Levothyroxine adsorbs to calcium carbonate in an acidic environment, which may reduce its bioavailability. 相似文献
996.
997.
998.
999.
Wei Yue Steven J. Santner Shigeru Masamura Ji-Ping Wang Laurence M. Demers Christopher Hamilton Richard J. Santen 《Breast cancer research and treatment》1998,49(1):S1-S7
Estradiol stimulates the growth of breast tumor cells in both pre- and post menopausal women. Following the menopause, the levels of estradiol in breast tumor tissues are similar to those from tumors obtained prior to cessation of ovarian function, even though plasma estrogen levels are 10–50 fold lower in post- than in premenopausal women. These observations suggested the possibility of enhanced estradiol uptake from plasma or in situ synthesis in post-menopausal women. We systematically studied these possibilities in a series of model systems. Initially we demonstrated a very high affinity estradiol binding site in tissues from castrated rats. Enhanced uptake occurred under conditions of low plasma estrogen levels when compared to animals with higher estradiol levels. In situ synthesis also occurred both through the sulfatase and aromatase pathways. In further studies, we compared uptake from plasma with in situ synthesis via aromatase in a nude mouse model. Under the conditions utilized, in situ synthesis resulted in much higher tissue estradiol levels and tumor growth rates than did uptake from plasma. During these studies we demonstrated that tumors deprived of estradiol developed mechanisms rendering them more sensitive to estrogen. This involved the ability of cells to adapt to estradiol deprivation to allow them to be responsive to four log lower amounts of estrogen than when studied under wild type conditions. In addition, cells adapted by increasing their level of aromatase and thus developing the capability to become more sensitive to estrogen precursors. Taken together, these studies demonstrate that breast cancer tissue is highly plastic and can adapt to conditions of estrogen deprivation via a variety of mechanisms. 相似文献
1000.